Nantong JiangTian Chemical Co., Ltd.

SZSE:300927.SZ

15.96 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Revenue 179.899171.299179.503169.265168.855191.495185.946174.176184.349192.824192.198169.266176.438172.073127.95298.713105.579105.462126.913113.82
Cost of Revenue 154.202142.625147.142136.825135.185147.471159.526144.867150.607148.095149.146139.773138.965134.209110.38468.2766.40482.87557.610
Gross Profit 25.69728.67432.36132.44133.6744.02426.4229.30933.74244.72943.05229.49337.47437.86317.56830.44339.17522.58769.303113.82
Gross Profit Ratio 0.1430.1670.180.1920.1990.230.1420.1680.1830.2320.2240.1740.2120.220.1370.3080.3710.2140.5461
Reseach & Development Expenses 1.0811.2222.8691.6791.7751.6791.4921.7511.7591.3921.7761.9181.7141.4552.4551.4651.9861.13818.9830
General & Administrative Expenses -2.1736.738-10.94615.995-0.5647.219-16.21721.963-3.6588.771-13.25819.541-2.2557.8873.04910.024-7.8744.6120.6170
Selling & Marketing Expenses 3.0032.9683.0662.9833.1982.7553.3782.622.5072.4143.1122.1532.4482.267-10.7086.60510.9640.9928.9990
SG&A 10.1439.706-7.8818.9782.6349.974-12.83924.584-1.15111.185-10.14621.6940.19310.154-7.65916.6283.0895.648.9710
Other Expenses -0.8870.004-0.1480.0650.01-0.014-0.098-0.004-0.0980.004-0.002-0.2070.0151.865-0.011-1.4122.8680.995-118.601-97.432
Operating Expenses 11.22412.01214.50112.22415.1412.7310.49314.95513.74113.43416.89213.34114.04712.0051.09215.13919.737.538-118.601-97.432
Operating Income 14.47316.46218.31819.42621.38130.2615.6614.99820.57531.55223.79616.45822.63323.57614.0114.81218.89414.0478.31316.388
Operating Income Ratio 0.080.0960.1020.1150.1270.1580.0840.0860.1120.1640.1240.0970.1280.1370.1090.150.1790.1330.0650.144
Total Other Income Expenses Net 1.852-0.196-1.0280.0650.01-0.014-0.12-0.004-0.0980.004-0.014-0.2070.0151.865-0.0110.0031.4530.9951.910.002
Income Before Tax 16.32516.46618.21319.49121.3930.24715.5414.99420.47731.55723.78216.25122.64725.44113.99814.81520.34715.04210.22316.39
Income Before Tax Ratio 0.0910.0960.1010.1150.1270.1580.0840.0860.1110.1640.1240.0960.1280.1480.1090.150.1930.1430.0810.144
Income Tax Expense 3.6684.023.6184.8124.9397.4252.5523.7974.6287.7962.6052.4673.3733.8511.472.3283.1122.2881.0562.404
Net Income 12.65712.44614.59414.67916.45222.82212.98811.19615.84923.76121.17813.78419.27421.5912.52812.48717.23612.7549.16713.987
Net Income Ratio 0.070.0730.0810.0870.0970.1190.070.0640.0860.1230.110.0810.1090.1250.0980.1270.1630.1210.0720.123
EPS 0.0880.0860.10.10.110.160.090.0780.110.160.150.0960.130.150.120.120.160.120.0850
EPS Diluted 0.0880.0860.10.10.110.160.090.0780.110.160.150.0960.130.150.120.120.160.120.0850
EBITDA 22.70417.54117.90520.92821.82531.91317.31615.5321.38133.01423.87116.57123.41227.53120.16317.50623.03916.159-297.053113.82
EBITDA Ratio 0.1260.1020.10.1240.1290.1670.0930.0890.1160.1710.1240.0980.1330.160.1580.1770.2180.153-2.3411